Tag: SCS

proclaim abbott

FDA approves low-dose spinal cord stimulator for chronic pain

Abbott has received FDA approval for its Proclaim XR recharge-free neurostimulation system for people with chronic pain. A press release reports that the Proclaim...
saluda medical evoke

Saluda Medical announces European commercial launch of Evoke, the ECAP-controlled, closed-loop...

Saluda Medical has announced the award of CE mark and the European commercial launch of the Evoke ECAP-controlled, closed-loop spinal cord stimulation (SCS) system...
pain scores SCS trial

Low pain scores following spinal cord stimulation trials found predictive of...

Low pain scores after spinal cord stimulation (SCS) trials are predictive of successful SCS implants with high sensitivity, according to a recent study. The...
Evoke Lawrence Poree INS SCS

The clinical utility of evoked compound action potentials is echoed by...

New data from both the Evoke and Avalon studies reiterate the importance of objective neurophysiological measures and clinically meaningful outcomes. These studies evaluated the...

Nevro announces completion of patient enrolment in multicentre RCT of high...

Nevro has announced that it has completed patient enrolment in its prospective, multicentre randomised controlled trial (RCT) for the treatment of chronic pain for...

Similar success rates for anatomic and targeted lead placement for spinal...

“Anatomical lead placement is a viable alternative to targeted lead placement for spinal cord stimulation,” concluded Jason E Pope, Evolve Restorative Center, Santa Rosa,...

The first wireless spinal cord stimulator system elicits a high response...

A study evaluating different waveforms within a wireless spinal cord stimulator (SCS) device (Stimwave) has found high response rates for patients receiving both high...

Placebo-controlled RCTs of spinal cord stimulation are on the rise, but...

Important methodological aspects of clinical trials of spinal cord stimulation (SCS) using a placebo are consistently being poorly reported, says a recent systematic review....

Key findings from a review of the indications, complications, and incidence...

A retrospective database review of 12,297 spinal cord stimulator (SCS) patients outlines key findings concerning the indications, incidence of minor and major complications, and...

Abbott partners with NIH on BRAIN initiative to advance research for...

Abbott have announced that it has partnered with the National Institutes of Health (NIH) on the BRAIN (Brain Research through Advancing Innovative Neurotechnologies) initiative...

Stimwave announces publication of 10 kHz Freedom Stimulator SURF RCT results

Stimwave has announced publication of the results of the first ever randomised, controlled trial (RCT) comparing wireless high-frequency (HF: 10 kHz) spinal cord stimulation...

Novel differential-target multiplexed technique outperforms conventional SCS

Continuous differential-target multiplexed (DTM) spinal cord stimulation (SCS) provides better thermal and mechanically induced pain relief compared to high-rate and low-rate SCS, concluded Ricardo...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

Evoke: The first RCT to measure spinal cord activations in response...

The protocol design for a multicentre, prospective, randomised, double-blind study comparing ECAP- (evoked compound action potential) controlled closed-looped with open-loop, fixed output spinal cord...

Majority of radiculopathy patients prefer burst to conventional tonic stimulation

BurstDR stimulation confers a greater reduction in leg and back pain intensity on patients with failed back surgery syndrome that tonic stimulation does, a...

Nuvectra receives full-body MR-conditional CE Mark approval for Algovita

Nuvectra has announced that it has received full-body MR-conditional approval for the Company’s Algovita spinal cord stimulation (SCS) system from its European Notified Body,...

Nuvectra receives FDA head-only MR-conditional approval for Algovita

Nuvectra has announced that it has received US Food and Drug Administration (FDA) head-only MR-conditional approval for the company’s Algovita spinal cord stimulation (SCS) system. Scott...